Coeptis Therapeutics, Inc.
COEP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,877 | -$21,267 | -$37,574 | -$13,449 |
| Dep. & Amort. | $1,039 | $1,036 | $1,001 | $447 |
| Deferred Tax | $0 | $0 | $0 | $5,337 |
| Stock-Based Comp. | $1,105 | $478 | $0 | $1,898 |
| Change in WC | -$125 | $1,727 | -$550 | -$2,980 |
| Other Non-Cash | $2,210 | $10,787 | $33,247 | $4,258 |
| Operating Cash Flow | -$6,649 | -$7,240 | -$3,876 | -$4,489 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$1,750 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$1,750 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,199 | -$575 | -$2,417 | -$1,622 |
| Stock Issued | $100 | $5,292 | $3,271 | $10,137 |
| Stock Repurch. | $0 | $0 | $0 | -$247 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,414 | $200 | $4,633 | -$51 |
| Financing Cash Flow | $5,713 | $4,917 | $5,488 | $8,216 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$936 | -$2,322 | $1,612 | $1,977 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,469 | $3,791 | $2,180 | $203 |
| End Cash | $533 | $1,469 | $3,791 | $2,180 |
| Free Cash Flow | -$6,649 | -$7,240 | -$3,876 | -$6,239 |